Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99


Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis.

El Touny LH, Banerjee PP.

Cancer Res. 2009 Apr 15;69(8):3695-703. doi: 10.1158/0008-5472.CAN-08-2958. Epub 2009 Apr 7.


Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).

Mentor-Marcel R, Lamartiniere CA, Eltoum IA, Greenberg NM, Elgavish A.

J Nutr. 2005 May;135(5):989-95.


Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).

Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A.

Cancer Res. 2001 Sep 15;61(18):6777-82.


Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells.

El Touny LH, Banerjee PP.

Biochem Biophys Res Commun. 2007 Sep 14;361(1):169-75. Epub 2007 Jul 16.


MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, Wellman K, Killmer J, Huang X, Scheidt KA, Montgomery RB, Bergan RC.

J Natl Cancer Inst. 2009 Aug 19;101(16):1141-55. doi: 10.1093/jnci/djp227. Epub 2009 Jul 28.


A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.

Liu H, Chen A, Guo F, Yuan L.

Cancer Lett. 2010 Sep 1;295(1):27-37. doi: 10.1016/j.canlet.2010.02.012. Epub 2010 Mar 6.


Genistein alters growth factor signaling in transgenic prostate model (TRAMP).

Wang J, Eltoum IE, Lamartiniere CA.

Mol Cell Endocrinol. 2004 Apr 30;219(1-2):171-80.


Dietary genistein inhibits metastasis of human prostate cancer in mice.

Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, Helenowski I, Pelling JC, Bergan RC.

Cancer Res. 2008 Mar 15;68(6):2024-32. doi: 10.1158/0008-5472.CAN-07-1246.


Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.

Venier NA, Yamamoto T, Sugar LM, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V.

Prostate. 2015 Sep;75(12):1300-11. doi: 10.1002/pros.23013. Epub 2015 Jun 5.


Genistein increases epidermal growth factor receptor signaling and promotes tumor progression in advanced human prostate cancer.

Nakamura H, Wang Y, Kurita T, Adomat H, Cunha GR, Wang Y.

PLoS One. 2011;6(5):e20034. doi: 10.1371/journal.pone.0020034. Epub 2011 May 16.


Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model.

Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Hafeli UO, Fu P, Mukhtar H.

Cancer Res. 2004 May 1;64(9):3334-43.


Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.

Harper CE, Cook LM, Patel BB, Wang J, Eltoum IA, Arabshahi A, Shirai T, Lamartiniere CA.

Prostate. 2009 Nov 1;69(15):1668-82. doi: 10.1002/pros.21017.


Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.

Peternac D, Klima I, Cecchini MG, Schwaninger R, Studer UE, Thalmann GN.

Prostate. 2008 Sep 1;68(12):1307-18. doi: 10.1002/pros.20795.


Genistein chemoprevention of prostate cancer in TRAMP mice.

Wang J, Eltoum IE, Lamartiniere CA.

J Carcinog. 2007 Mar 16;6:3.


Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.

Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC.

IUBMB Life. 2005 Jun;57(6):441-7. Review.

Supplemental Content

Support Center